TLR4 and Barrett esophagus: We also found an improvement in inflammation in white adipose tissue (WAT) and the liver in BE-treated mice, as indicated by the reduced mRNA expression of TLR4, IL-6, and TNF-α and the decreased adipocyte size in the WAT (Figures 2C, 2F and 2G).